Automated screening of COVID-19 preprints: can we help authors to improve transparency and reproducibility?

Affiliations

• ¹ Quality | Ethics | Open Science | Translation (QUEST), Berlin Institute of Health, Berlin, Germany. tracey.weissgerber@charite.de.
• ² Charité-Universitätsmedizin Berlin, Berlin, Germany. tracey.weissgerber@charite.de.
• ³ Quality | Ethics | Open Science | Translation (QUEST), Berlin Institute of Health, Berlin, Germany.
• ⁴ School of Information Sciences, University of Illinois at Urbana-Champaign, Champaign, IL, USA.
• ⁵ University Grenoble Alpes, CNRS, Grenoble INP, LIG, Grenoble, France.
• ⁶ Department of Neuroscience, University of California, San Diego, La Jolla, CA, USA.
• ⁷ SciCrunch Inc., San Diego, CA, USA.
• ⁸ Department of Cardiology, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
• ⁹ Urban Vitality Center of Expertise, Amsterdam University of Applied Sciences, Amsterdam, the Netherlands.
• ¹⁰ New South Wales Health Statewide Biobank, New South Wales Health Pathology, Sydney, New South Wales, Australia.
• ¹¹ Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
• ¹² UMR 5505 IRIT, Université de Toulouse, UPS, Toulouse, France.
• ¹³ CellBank Australia, Children's Medical Research Institute and The University of Sydney, Westmead, NSW, Australia.
• ¹⁴ University Grenoble Alpes, TIMC UMR5525, La Tronche, France.
• ¹⁵ California Institute of Technology, Pasadena, CA, USA.
• ¹⁶ Charité-Universitätsmedizin Berlin, Berlin, Germany.
• ¹⁷ NeuroCure Cluster of Excellence, Charité-Universitätsmedizin Berlin, corporate member of the Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.